<bill session="117" type="s" number="2146" updated="2022-12-31T05:26:48Z">
  <state datetime="2021-06-21">REFERRED</state>
  <status>
    <introduced datetime="2021-06-21"/>
  </status>
  <introduced datetime="2021-06-21"/>
  <titles>
    <title type="official" as="introduced">A bill to establish within the Office of the Secretary of Health and Human Services a special task force on ensuring Medicare beneficiary access to innovative diabetes technologies and services.</title>
    <title type="display">Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021</title>
    <title type="short" as="introduced">Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021</title>
  </titles>
  <sponsor bioguide_id="C001035"/>
  <cosponsors>
    <cosponsor bioguide_id="S001181" joined="2021-06-21"/>
  </cosponsors>
  <actions>
    <action datetime="2021-06-21">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-06-21" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S4657" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health care coverage and access"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2021-07-20T20:55:33Z" status="Introduced in Senate">Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021

This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.

Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare &amp; Medicaid Services to streamline approval and coverage.</summary>
</bill>
